aTYR PHARMA INC Quarterly Weighted Average Number of Shares Outstanding, Diluted from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
aTYR PHARMA INC quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2019 to Q2 2024.
  • aTYR PHARMA INC Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2024 was 72.3M shares, a 31.1% increase year-over-year.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 53.6M shares, a 88.6% increase from 2022.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 28.4M shares, a 48.9% increase from 2021.
  • aTYR PHARMA INC annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 19.1M shares, a 108% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 72.3M +17.1M +31.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-13
Q1 2024 66.1M +24.2M +57.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 53.6M +25.2M +88.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-14
Q3 2023 57.9M +29.2M +102% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 55.1M +27.1M +96.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 41.9M +14.1M +50.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 28.4M +9.34M +48.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-14
Q3 2022 28.7M +10.5M +57.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 28.1M +11.9M +74% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 27.8M +13.7M +97.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 19.1M Oct 1, 2021 Dec 31, 2021 10-K 2024-03-14
Q3 2021 18.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 16.1M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 14.1M +7.22M +105% Jan 1, 2021 Mar 31, 2021 10-Q 2021-05-14
Q1 2020 6.88M +4.47M +185% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-14
Q1 2019 2.42M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.